CSI Market
Sign In | Register

Korro Bio Inc (KRRO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access KRRO quarterly Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Korro Bio Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-117.26
Depreciation & amortization4.28
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-1.59
Asset Impairment Charges30.89
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.06
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Deferred Lease Incentives-
Increase Decrease In Deferred Financing Costs And Other Assets-
Increase Decrease In Royalties Payable Excluding Accounts Payable-
Increase Decrease In Contract With Customer Liability-
Non Cash Lease Expenses0.73
Increase Decrease In Lease Liabilities-1.28
Increase Decrease In Lease Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.73
Increase (Decrease) in Accounts Payable-2.31
Increase (Decrease) in Accrued Liabilities1.43
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.67
Other Working Capital0.27
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities7.17
Discontinued operations0.00
Net Cash flow from Operating Activities-78.56
Investing Activities
Capital Expenditures-0.52
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Marketable Securities-26.19
Real Estate Investments0.00
Payment For Proceeds From Sale Of Available For Sale Securities Debt-
Proceeds From Payment For Property And Equipment-
Advance Payments For Property And Equipment Not Yet Received-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Maturities, Prepayments and Calls of Other Investments70.70
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities43.99
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.69
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-59.05
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations59.05
Capital Expenditures Incurred But Not Yet Paid-
Debt Conversion Converted Instrument Amount-
Non Cash Dividend On Cumulative Convertible Preferred Stock-
Conversion Of Stock Amount Issued-
Cash Acquired In Connection With The Reverse Recapitalization-
Payment Of Reverse Recapitalization Transaction Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.69
Effect of exchange rate on cash flow0.06
Discontinued operations0.00
Free Cash Flow-79.08
Total Cash Flow-33.82
4 historic quarters locked

Sign in to unlock the full Korro Bio Inc cash flow history.

Sign In Create Free Account

About Korro Bio Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-104156

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License